Drugs for discoid lupus erythematosus [PDF]
Discoid lupus erythematosus (DLE) is a chronic form of cutaneous lupus, which can cause scarring. Many drugs have been used to treat this disease and some (such as thalidomide, cyclophosphamide and azathioprine) are potentially toxic. This is an update of a Cochrane Review first published in 2000, and previously updated in 2009. We wanted to update the
Whitelaw Da+3 more
openaire +8 more sources
Treatment of discoid lupus erythematosus scarring alopecia with deucravacitinib: A case report [PDF]
Discoid lupus erythematosus is a chronic, recurring, autoimmune skin disease causing annular, scarring plaques on the head and neck. Deucravacitinib, a tyrosine kinase 2 inhibitor in the Janus kinase inhibitor family, represents an emerging treatment ...
Katherine Aw, Genevieve Gavigan
doaj +2 more sources
Oral ulcerative lesions are very common and a proper diagnosis is required of the nonresponsive lesions to common antiseptic and analgesic creams which do not work on those ulcers. Specific local potent steroids work faster with given soft trays to apply,
Anilkumar L Bhoweer, Sudarshan G Ranpise
doaj +2 more sources
Can Dermoscopy Be a Useful Follow-Up Tool in Patients with Discoid Lupus Treated with Anifrolumab? [PDF]
This report discusses a female patient with longstanding discoid lupus erythematosus (DLE) and systemic lupus erythematosus (SLE), refractory to multiple immunosuppressive and biologic treatments. Upon presenting with infiltrated, hypertrophic plaques in
Francesca Ambrogio+7 more
doaj +2 more sources
The Need to Improve the Medical Subject Headings (MeSH) and the Excerpta Medica Tree (EMTREE) Thesauri to Perform Systematic Review on Oral Potentially Malignant Disorders. [PDF]
ABSTRACT Background Despite recent advancements in the understanding and classification of oral potentially malignant disorders (OPMD), their terminology remains inconsistent and heterogeneous throughout the scientific literature, thus affecting evidence‐based decision‐making relevant for clinical management of these disorders.
Caponio VCA+5 more
europepmc +2 more sources
Lupus erythematosus panniculitis (LEP) is a rare variant of cutaneous lupus erythematosus (1%–3% of CLE). There are two case reports to date in the literature of LEP potentially triggered by anti‐TNF‐α therapies. Clinically, it is characterised by tender,
Cristina Grechin+4 more
doaj +2 more sources
Apoptosis in chronic cutaneous lupus erythematosus, discoid lupus, and lupus profundus. [PDF]
: Introduction: Lupus erythematosus is a multisystemic disease that is characterized by autoantibody production and immune complex deposition in such tissues as the mucosa, joints, the central nervous system, and skin.
Sáenz-Corral CI+7 more
europepmc +3 more sources
Linear cutaneous lupus erythematosus/discoid lupus erythematosus in an adult. [PDF]
Mao QX+9 more
europepmc +5 more sources
Different distribution patterns of plasmacytoid dendritic cells in discoid lupus erythematosus and lichen planopilaris demonstrated by CD123 immunostaining, [PDF]
Background: Clinical and histological features may overlap between lichen planopilaris-associated and discoid lupus erythematosus-associated scarring alopecia.
Azadeh Rakhshan+4 more
doaj +1 more source
Scalp involvement with hair loss is common in systemic lupus erythematosus. Discoid lupus erythematosus may cause scarring alopecia, characterized by well-delimited erythematous plaques with scales, follicular hyperkeratosis and atrophy, which is ...
Cleide Garbelini-Lima+5 more
doaj +1 more source